Non-alcoholic fatty liver disease (NAFLD) is a common liver disorder in which there is an accumulation of fat in the liver cells. This condition is often associated with obesity, diabetes, and metabolic syndrome. NAFLD can cause liver inflammation and fibrosis, and in severe cases, it can lead to cirrhosis and liver failure. Therefore, finding effective ways to treat NAFLD is crucial.
Recent studies have suggested that coffee consumption may have a beneficial effect on the liver. Coffee is one of the most widely consumed beverages in the world and has been associated with various health benefits, including a reduced risk of liver diseases. In particular, research has shown that coffee consumption may reduce the severity of NAFLD.
A study published in the Journal of Hepatology in 2019 investigated the effect of coffee consumption on NAFLD in patients with type 2 diabetes. The study included 274 patients with type 2 diabetes and NAFLD, divided into two groups: the coffee group (who consumed at least two cups of coffee per day) and the non-coffee group (who drank less than two cups of coffee per day).
After 24 weeks of follow-up, the researchers found that the coffee group had a significantly lower liver stiffness measurement (LSM) than the non-coffee group. LSM is a non-invasive method used to assess liver fibrosis, a key feature of NAFLD. The coffee group also significantly reduced serum alanine aminotransferase (ALT) levels, which is a marker of liver damage.
Another study published in the Journal of Gastroenterology and Hepatology in 2018 investigated the effect of coffee consumption on NAFLD in patients without diabetes. The study included 310 patients with NAFLD, who were divided into three groups: the coffee group (who consumed at least three cups of coffee per day), the non-coffee group (who drank less than one cup of coffee per day), and the intermediate coffee group (who consumed between one and three cups of coffee per day).
The researchers found that the coffee group had a significantly lower prevalence of advanced fibrosis than the non-coffee group. Advanced fibrosis is a severe form of liver fibrosis that can lead to cirrhosis and liver failure. The intermediate coffee group also had a lower prevalence of advanced fibrosis than the non-coffee group, but the difference was not statistically significant.
The beneficial effect of coffee on NAFLD may be due to its antioxidant and anti-inflammatory properties. Coffee contains various bioactive compounds, such as chlorogenic acid, caffeine, and polyphenols, which have been shown to have antioxidant and anti-inflammatory effects. These compounds may protect the liver from oxidative stress and inflammation, which are critical factors in the development and progression of NAFLD.
In conclusion, coffee consumption may benefit the liver and reduce the severity of NAFLD in diabetic and non-diabetic populations. However, more research is needed to confirm these findings and determine the optimal amount and duration of coffee consumption to prevent and treat NAFLD. Nevertheless, these studies suggest that coffee can be a simple and accessible way to promote liver health and to avoid liver diseases.
References & Similar Articles
- 2022 Study – https://www.mdpi.com/2072-6643/15/1/4
- https://pubmed.ncbi.nlm.nih.gov/36615664/
- https://www.sciencedirect.com/science/article/abs/pii/S1542356521010570
- https://onlinelibrary.wiley.com/doi/10.1111/apt.13523